Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. The company s R D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants...
Read More